• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗:2017年回顾

Percutaneous coronary intervention: 2017 in review.

作者信息

Rao Gaurav, Sheth Shikha, Grines Cindy

机构信息

Department of Cardiology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra Northwell, North Shore University Hospital, Manhasset, New York.

出版信息

J Interv Cardiol. 2018 Apr;31(2):117-128. doi: 10.1111/joic.12508. Epub 2018 Mar 25.

DOI:10.1111/joic.12508
PMID:29575110
Abstract

In an effort to keep the interventional community up-to-date with the abundant amount of new data, we have selected what we believe to be the most important publications in percutaneous coronary intervention from January 1, 2017 to December 2017.

摘要

为了让介入治疗领域的专业人士及时了解大量的新数据,我们挑选了我们认为是2017年1月1日至2017年12月期间经皮冠状动脉介入治疗方面最重要的出版物。

相似文献

1
Percutaneous coronary intervention: 2017 in review.经皮冠状动脉介入治疗:2017年回顾
J Interv Cardiol. 2018 Apr;31(2):117-128. doi: 10.1111/joic.12508. Epub 2018 Mar 25.
2
Surgical vs percutaneous coronary revascularization in patients with diabetes following an acute coronary syndrome.急性冠状动脉综合征后糖尿病患者的外科手术与经皮冠状动脉血运重建术对比
J Diabetes. 2019 Jul;11(7):610-612. doi: 10.1111/1753-0407.12917. Epub 2019 Apr 22.
3
Coronary Revascularization of Patients With Diabetes Mellitus in the Setting of Acute Coronary Syndromes.急性冠状动脉综合征背景下糖尿病患者的冠状动脉血运重建
Circulation. 2019 Oct 8;140(15):1233-1235. doi: 10.1161/CIRCULATIONAHA.119.040683. Epub 2019 Oct 7.
4
Percutaneous coronary intervention and recurrent hospitalizations in elderly patients with non ST-segment acute coronary syndrome: The role of frailty.老年非ST段抬高型急性冠脉综合征患者的经皮冠状动脉介入治疗与再入院:衰弱的作用
Int J Cardiol. 2017 Feb 1;228:456-458. doi: 10.1016/j.ijcard.2016.11.151. Epub 2016 Nov 10.
5
Percutaneous Coronary Intervention: 2015 in Review.
J Interv Cardiol. 2016 Feb;29(1):11-26. doi: 10.1111/joic.12272.
6
Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort.急性冠状动脉综合征中的血栓抽吸:在当代瑞士队列中,其流行率、操作成功率、连续肌钙蛋白 T 水平变化及临床结局。
Eur Heart J Acute Cardiovasc Care. 2018 Sep;7(6):522-531. doi: 10.1177/2048872617706480. Epub 2017 Apr 20.
7
Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm.
Catheter Cardiovasc Interv. 2016 Jan 1;87(1):90-100. doi: 10.1002/ccd.26034. Epub 2015 Jun 29.
8
Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes.
Am J Cardiol. 2014 Oct 1;114(7):1128-9. doi: 10.1016/j.amjcard.2014.07.003. Epub 2014 Jul 16.
9
Thrombus aspiration: Suck it up and keep looking for a niche.血栓抽吸:将其吸出并持续寻找合适的方法。
Catheter Cardiovasc Interv. 2016 Nov;88(5):725-726. doi: 10.1002/ccd.26822.
10
Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes (SMART-DATE) prospective multicenter randomized trial.急性冠状动脉综合征患者经皮冠状动脉介入治疗后6个月双联抗血小板治疗的安全性:智能血管成形术研究团队-急性冠状动脉综合征患者经皮冠状动脉介入治疗后6个月双联抗血小板治疗的安全性(SMART-DATE)前瞻性多中心随机试验的原理与设计
Am Heart J. 2016 Dec;182:1-8. doi: 10.1016/j.ahj.2016.07.022. Epub 2016 Aug 26.

引用本文的文献

1
Cardiac function and quality of life improvement with fasudil hydrochloride in patients with diabetes post-PCI: a randomized controlled trial.盐酸法舒地尔对PCI术后糖尿病患者心功能及生活质量的改善作用:一项随机对照试验
J Int Med Res. 2025 Feb;53(2):3000605241311403. doi: 10.1177/03000605241311403.
2
One Billion hiPSC-Cardiomyocytes: Upscaling Engineered Cardiac Tissues to Create High Cell Density Therapies for Clinical Translation in Heart Regeneration.十亿个人诱导多能干细胞来源的心肌细胞:扩大工程化心脏组织规模以创建用于心脏再生临床转化的高细胞密度疗法。
Bioengineering (Basel). 2023 May 13;10(5):587. doi: 10.3390/bioengineering10050587.
3
Risk factors associated with intra-stent restenosis after percutaneous coronary intervention.
经皮冠状动脉介入治疗后支架内再狭窄的相关危险因素。
Exp Ther Med. 2021 Oct;22(4):1141. doi: 10.3892/etm.2021.10575. Epub 2021 Aug 9.
4
Implementation of a clinical nursing pathway for percutaneous coronary intervention: A randomized controlled trial protocol.经皮冠状动脉介入治疗临床护理路径的实施:一项随机对照试验方案
Medicine (Baltimore). 2020 Oct 23;99(43):e22866. doi: 10.1097/MD.0000000000022866.